149 related articles for article (PubMed ID: 10803680)
1. Role of polymorphic CYP2E1 and CYP2D6 genes in NNK-induced chromosome aberrations in cultured human lymphocytes.
Abdel-Rahman SZ; Salama SA; Au WW; Hamada FA
Pharmacogenetics; 2000 Apr; 10(3):239-49. PubMed ID: 10803680
[TBL] [Abstract][Full Text] [Related]
2. Role of polymorphic GSTM1 and GSTT1 genotypes on NNK-induced genotoxicity.
Salama SA; Abdel-Rahman SZ; Sierra-Torres CH; Hamada FA; Au WW
Pharmacogenetics; 1999 Dec; 9(6):735-43. PubMed ID: 10634136
[TBL] [Abstract][Full Text] [Related]
3. A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6.
Crespi CL; Penman BW; Gelboin HV; Gonzalez FJ
Carcinogenesis; 1991 Jul; 12(7):1197-201. PubMed ID: 2070484
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in genetic damage induced by the tobacco-specific nitrosamine NNK and the influence of the Thr241Met polymorphism in the XRCC3 gene.
Hill CE; Affatato AA; Wolfe KJ; Lopez MS; Hallberg CK; Canistro D; Abdel-Rahman SZ
Environ Mol Mutagen; 2005 Jul; 46(1):22-9. PubMed ID: 15887211
[TBL] [Abstract][Full Text] [Related]
5. The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK.
Abdel-Rahman SZ; El-Zein RA
Cancer Lett; 2000 Oct; 159(1):63-71. PubMed ID: 10974407
[TBL] [Abstract][Full Text] [Related]
6. Interactions between genetic predisposition and environmental toxicants for development of lung cancer.
el-Zein R; Conforti-Froes N; Au WW
Environ Mol Mutagen; 1997; 30(2):196-204. PubMed ID: 9329644
[TBL] [Abstract][Full Text] [Related]
7. [Relation between cytochrome P450 2D6 and lung cancer susceptibility caused by smoking].
Yan Z; Wu Y; Wu Y
Wei Sheng Yan Jiu; 2007 Jan; 36(1):112-3, 116. PubMed ID: 17424863
[TBL] [Abstract][Full Text] [Related]
8. Effect of XPD/ERCC2 polymorphisms on chromosome aberration frequencies in smokers and on sensitivity to the mutagenic tobacco-specific nitrosamine NNK.
Affatato AA; Wolfe KJ; Lopez MS; Hallberg C; Ammenheuser MM; Abdel-Rahman SZ
Environ Mol Mutagen; 2004; 44(1):65-73. PubMed ID: 15199548
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate.
Smith TJ; Guo Z; Guengerich FP; Yang CS
Carcinogenesis; 1996 Apr; 17(4):809-13. PubMed ID: 8625495
[TBL] [Abstract][Full Text] [Related]
10. Study of the association between cytochromes P450 2D6 and 2E1 genotypes and the risk of drug and chemical induced idiosyncratic aplastic anaemia.
Marsh JC; Chowdry J; Parry-Jones N; Ellis SW; Muir KR; Gordon-Smith EC; Tucker GT
Br J Haematol; 1999 Feb; 104(2):266-70. PubMed ID: 10050706
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in lung tissue from mouse, rat, hamster, and man.
Richter E; Engl J; Friesenegger S; Tricker AR
Chem Res Toxicol; 2009 Jun; 22(6):1008-17. PubMed ID: 19408892
[TBL] [Abstract][Full Text] [Related]
12. In vitro genotoxicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone activated by hamster maternal and fetal tissues.
Alaoui-Jamali MA; Castonguay A; Schuller HM
Carcinogenesis; 1988 Dec; 9(12):2319-24. PubMed ID: 3191579
[TBL] [Abstract][Full Text] [Related]
13. The L84F and the I143V polymorphisms in the O6-methylguanine-DNA-methyltransferase (MGMT) gene increase human sensitivity to the genotoxic effects of the tobacco-specific nitrosamine carcinogen NNK.
Hill CE; Wickliffe JK; Wolfe KJ; Kinslow CJ; Lopez MS; Abdel-Rahman SZ
Pharmacogenet Genomics; 2005 Aug; 15(8):571-8. PubMed ID: 16007001
[TBL] [Abstract][Full Text] [Related]
14. Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in aborigines from western Australia.
Griese EU; Ilett KF; Kitteringham NR; Eichelbaum M; Powell H; Spargo RM; LeSouef PN; Musk AW; Minchin RF
Pharmacogenetics; 2001 Feb; 11(1):69-76. PubMed ID: 11207032
[TBL] [Abstract][Full Text] [Related]
15. Expression and NNK reducing activities of carbonyl reductase and 11beta-hydroxysteroid dehydrogenase type 1 in human lung.
Finckh C; Atalla A; Nagel G; Stinner B; Maser E
Chem Biol Interact; 2001 Jan; 130-132(1-3):761-73. PubMed ID: 11306092
[TBL] [Abstract][Full Text] [Related]
16. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.
Silvestri L; Sonzogni L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Leveri M; Cividini A; Mondelli MU; Civardi E; Silini EM
Int J Cancer; 2003 Apr; 104(3):310-7. PubMed ID: 12569554
[TBL] [Abstract][Full Text] [Related]
17. Genoprotection by UDP-glucuronosyltransferases in peroxidase-dependent, reactive oxygen species-mediated micronucleus initiation by the carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene.
Kim PM; Wells PG
Cancer Res; 1996 Apr; 56(7):1526-32. PubMed ID: 8603397
[TBL] [Abstract][Full Text] [Related]
18. Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13.
Jalas JR; Ding X; Murphy SE
Drug Metab Dispos; 2003 Oct; 31(10):1199-202. PubMed ID: 12975327
[TBL] [Abstract][Full Text] [Related]
19. CYP2D6, NAT2 and CYP2E1 genetic polymorphisms in nonagenarians.
Agúndez JA; Rodríguez I; Olivera M; Ladero JM; García MA; Ribera JM; Benítez J
Age Ageing; 1997 Mar; 26(2):147-51. PubMed ID: 9177672
[TBL] [Abstract][Full Text] [Related]
20. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.
Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF
Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
